Cargando…
hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC
BACKGROUND: Understanding how cancer signaling pathways promote an immunosuppressive program which sustains acquired or primary resistance to immune checkpoint blockade (ICB) is a crucial step in improving immunotherapy efficacy. Among the pathways that can affect ICB response is the interferon (IFN...
Autores principales: | Trono, Paola, Tocci, Annalisa, Palermo, Belinda, Di Carlo, Anna, D'Ambrosio, Lorenzo, D'Andrea, Daniel, Di Modugno, Francesca, De Nicola, Francesca, Goeman, Frauke, Corleone, Giacomo, Warren, Sarah, Paolini, Francesca, Panetta, Mariangela, Sperduti, Isabella, Baldari, Silvia, Visca, Paolo, Carpano, Silvia, Cappuzzo, Federico, Russo, Vincenzo, Tripodo, Claudio, Zucali, Paolo, Gregorc, Vanesa, Marchesi, Federica, Nistico, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450042/ https://www.ncbi.nlm.nih.gov/pubmed/37612043 http://dx.doi.org/10.1136/jitc-2023-006913 |
Ejemplares similares
-
hMENA(11a), a hMENA isoform sending survival signals
por: Trono, Paola, et al.
Publicado: (2015) -
The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer
por: Di Modugno, Francesca, et al.
Publicado: (2010) -
hMENA splicing program impacts the clinical outcome of early stage lung cancer patients. How and why?
por: Visca, Paolo, et al.
Publicado: (2014) -
The actin modulator hMENA regulates GAS6‐AXL axis and pro‐tumor cancer/stromal cell cooperation
por: Melchionna, Roberta, et al.
Publicado: (2020) -
hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis
por: Di Modugno, Francesca, et al.
Publicado: (2018)